{"schema_version":"secwatch.filing_event.v1","accession":"0001829126-26-009659","form_type":"8-K","ticker":"NXL","cik":"0001527352","company_name":"Nexalin Technology, Inc.","filed_at":"2026-09-02T20:50:24+00:00","discovered_at":"2026-09-02T20:51:02.473566+00:00","generated_at":"2026-09-02T20:51:06.175594+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Nexalin SVP Quality/Regulatory/Clinical Carolyn Shelton departs; separation terms set","bullets":["Carolyn Shelton departed as SVP of Quality, Regulatory, and Clinical Affairs on Aug 28, 2026.","Separation agreement includes one month of base salary and a $20,000 2026 bonus.","Unvested stock options accelerated; vested options exercisable for up to two years.","Health insurance premiums subsidized through Sept 30, 2026; includes release of claims and confidentiality/non-disparagement/cooperation.","Agreement to be filed as exhibit to next periodic report."],"urls":{"canonical":"https://secwatch.observer/filing/0001829126-26-009659","json":"https://secwatch.observer/filing/0001829126-26-009659.json","markdown":"https://secwatch.observer/filing/0001829126-26-009659.md","text":"https://secwatch.observer/filing/0001829126-26-009659.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1527352/000182912626009659/0001829126-26-009659-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1527352/000182912626009659/nexalintec_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-09-02T20:51:06.175594+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"fd857b12b8","claim":"Carolyn Shelton departed as Senior Vice President of Quality, Regulatory, and Clinical Affairs at Nexalin Technology, Inc..","evidence_excerpt":"On August 28, 2026, Carolyn Shelton departed from her role as Senior Vice President of Quality, Regulatory, and Clinical Affairs of Nexalin Technology, Inc. (the “Company”).","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1527352/000182912626009659/0001829126-26-009659-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"departed"},{"label":"Role","value":"Senior Vice President of Quality, Regulatory, and Clinical Affairs"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}